Chronic kidney disease (CKD) as identified by a reduced estimated glomerular filtration rate
(eGFR) is a common comorbidity in patients with heart failure with reduced ejection fraction …

Abstract Purpose of Review The incidence of chronic kidney disease is increasing
worldwide, and the previously decreasing incidence of cardiovascular disease has now …

Background Few contemporary data exist evaluating care patterns and outcomes in heart
failure (HF) across the spectrum of kidney function. Objectives This study sought to …

Aims Multimorbidity is common among heart failure (HF) patients and may attenuate
guideline‐directed medical therapy (GDMT). Multimorbid patients are under‐represented in …

Patients with the dual burden of chronic kidney disease (CKD) and chronic congestive heart
failure (HF) experience unacceptably high rates of symptom load, hospitalization, and …

Despite the high prevalence of chronic kidney disease (CKD) and its high cardiovascular
risk, patients with CKD, especially those with advanced CKD (stages 4–5 and patients on …

Consenso de expertos sobre la insuficiencia cardiaca con fracción de eyección reducida:
más allá de las guías | Rev. esp. cardiol. Supl. (Ed. impresa);20(supl.B): 1-46, abr. 2020. ilus …

Background: It is unknown if β-blockers reduce mortality/morbidity in patients with heart
failure (HF) and advanced chronic kidney disease (CKD), a population underrepresented in …

Heart failure with reduced ejection fraction (HFrEF) is an increasing global pandemic
affecting more than 30 million individuals worldwide. Importantly, HFrEF is frequently …

End-stage kidney disease (ESKD) and heart failure (HF) often coexist and must be managed
simultaneously. Multidisciplinary collaboration between nephrology and cardiology is critical …